Cholesterol and Alzheimer's disease; from risk genes to pathological effects

FM Feringa, R Van der Kant - Frontiers in Aging Neuroscience, 2021 - frontiersin.org
While the central nervous system compromises 2% of our body weight, it harbors up to 25%
of the body's cholesterol. Cholesterol levels in the brain are tightly regulated for …

Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and Alzheimer's disease

G Verdile, KN Keane, VF Cruzat, S Medic… - Mediators of …, 2015 - Wiley Online Library
Type 2 diabetes (T2DM), Alzheimer's disease (AD), and insulin resistance are age‐related
conditions and increased prevalence is of public concern. Recent research has provided …

Comprehensive evaluation of the 5XFAD mouse model for preclinical testing applications: a MODEL-AD study

AL Oblak, PB Lin, KP Kotredes, RS Pandey… - Frontiers in aging …, 2021 - frontiersin.org
The ability to investigate therapeutic interventions in animal models of neurodegenerative
diseases depends on extensive characterization of the model (s) being used. There are …

Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease

RE Bennett, AB Robbins, M Hu, X Cao… - Proceedings of the …, 2018 - National Acad Sciences
Mixed pathology, with both Alzheimer's disease and vascular abnormalities, is the most
common cause of clinical dementia in the elderly. While usually thought to be concurrent …

Resveratrol: French paradox revisited

B Catalgol, S Batirel, Y Taga, NK Ozer - Frontiers in pharmacology, 2012 - frontiersin.org
Resveratrol is a polyphenol that plays a potentially important role in many disorders and has
been studied in different diseases. The research on this chemical started through the …

The role of type 2 diabetes in neurodegeneration

G Verdile, SJ Fuller, RN Martins - Neurobiology of disease, 2015 - Elsevier
A growing body of evidence links type-2 diabetes (T2D) with dementia and
neurodegenerative diseases such as Alzheimer's disease (AD). AD is the most common …

Is Alzheimer's disease risk modifiable?

A Serrano-Pozo, JH Growdon - Journal of Alzheimer's disease, 2019 - content.iospress.com
Population-based clinic-pathological studies have established that the most common
pathological substrate of dementia in community-dwelling elderly people is mixed …

Current understanding of the physiopathology, diagnosis and therapeutic approach to Alzheimer's disease

V García-Morales, A González-Acedo… - Biomedicines, 2021 - mdpi.com
Alzheimer's disease (AD) is the most common cause of dementia. It is characterized by
cognitive decline and progressive memory loss. The aim of this review was to update the …

Mechanistic link between vitamin B12 and Alzheimer's disease

AA Lauer, HS Grimm, B Apel, N Golobrodska, L Kruse… - Biomolecules, 2022 - mdpi.com
Alzheimer's disease (AD) is the most common form of dementia in the elderly population,
affecting over 55 million people worldwide. Histopathological hallmarks of this multifactorial …

Regulation of cholesterol and sphingomyelin metabolism by amyloid-β and presenilin

MOW Grimm, HS Grimm, AJ Pätzold, EG Zinser… - Nature cell …, 2005 - nature.com
Amyloid beta peptide (Aβ) has a key role in the pathological process of Alzheimer's disease
(AD), but the physiological function of Aβ and of the amyloid precursor protein (APP) is …